The global antidiarrhoeals market will grow from $3.81 billion in 2022 to $3.94 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The antidiarrhoeals market is expected to grow to $4.31 billion in 2027 at a CAGR of 2.3%.
The antidiarrheal drugs market consists of sales loperamide hydrochloride, Bismuth subsalicylate, Pepto Bismol and Imodium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The antidiarrheal drugs refer to drugs that relieve the frequent passing of a watery, loose stool, one of the symptoms of diarrhoea. According to their shared chemical or functional properties, antidiarrheal medications can generally be grouped into three groups: adsorbents, antimotility agents, and bacterial replacements (probiotics).
The main classes of antidiarrhoeals drugs are mucosal protectants and motility modifying drugs. Mucosal protective agents are drugs that safeguard the stomach’s mucosal lining from gastric acid and are employed to cure peptic ulcers. The different types include OTC drugs, and prescription drugs, which are used by adults and children.
The rise in the number of diarrhea cases significantly contributes to the growth of the antidiarrheal drug market. According to UNICEF, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. An increasing number of diarrheal cases increases the demand for antidiarrheal drugs.
An increase in the use of biologics medicines poses to be a restraint to the antidiarrheal market. Biologics are medicines derived from living organisms like human beings, animals, or other microorganisms using biotechnology and are composed of proteins, sugar, nucleic acids, or a combination of each of these substances. Due to their ability to target inaccessible parts using small-molecule therapies, biologics are being preferred over traditional chemical drugs. This shift is restricting the antidiarrheal drugs market hampering its growth of the market. For example, to treat Crohn’s Disease, antidiarrheal medications were being used previously, but with the advent of biologics, demand for antidiarrheal diseases has subsided.
Major companies in the antidiarrheal drug market are merging with other companies in the market to increase their reach and market share. Companies merge with or acquire other companies to expand their market share, diversify their product portfolio, or acquire new technologies. For instance, GlaxoSmithKline agreed to acquire Novartis AG's 36.5% stake in the consumer healthcare business for $ 13 billion to expand the market.
The antidiarrheal drug industry is governed by regulatory frameworks by agencies such as US Food and Drug Administration Agency (FDA). FDA's guidelines for antidiarrheal drugs are mentioned within the CFR's (Code for Federal Regulations) title number 21 under part 335 which gives guidelines for the over-the-counter (OTC) human use of the antidiarrheal drugs. Subpart C of the regulation focuses on the labeling aspect of such drugs and mandates a statement of identity, which identifies the product is to be used for diarrhea to avoid any improper use of the drug. The FDA also regulates the warnings and directions of use of the drugs which are to be printed on the cover of these drugs.
In March 2020, Arcadia Consumer Healthcare, Inc., a USA-based pharmaceutical company acquired the Kaopectate brand from Sanofi for an undisclosed amount. This acquisition enhanced Sanofi’s product portfolio by providing consumers with simple, efficacious, and high-quality solutions. Sanofi, is a France-based biopharmaceutical company focused on human health.
The regions covered in the antidiarrhoeals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antidiarrhoeals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The antidiarrheal drugs market research report is one of a series of new reports that provides antidiarrheal drugs market statistics, including antidiarrheal drugs industry global market size, regional shares, competitors with antidiarrheal drugs market share, detailed antidiarrheal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the antidiarrheal drugs industry. This antidiarrheal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the antidiarrhoeals market are GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals, Merck & Co., Pfizer, Proctor & Gamble, Sanofi Aventis and Bayer.
This product will be delivered within 3-5 business days.
The antidiarrheal drugs market consists of sales loperamide hydrochloride, Bismuth subsalicylate, Pepto Bismol and Imodium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The antidiarrheal drugs refer to drugs that relieve the frequent passing of a watery, loose stool, one of the symptoms of diarrhoea. According to their shared chemical or functional properties, antidiarrheal medications can generally be grouped into three groups: adsorbents, antimotility agents, and bacterial replacements (probiotics).
The main classes of antidiarrhoeals drugs are mucosal protectants and motility modifying drugs. Mucosal protective agents are drugs that safeguard the stomach’s mucosal lining from gastric acid and are employed to cure peptic ulcers. The different types include OTC drugs, and prescription drugs, which are used by adults and children.
The rise in the number of diarrhea cases significantly contributes to the growth of the antidiarrheal drug market. According to UNICEF, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. An increasing number of diarrheal cases increases the demand for antidiarrheal drugs.
An increase in the use of biologics medicines poses to be a restraint to the antidiarrheal market. Biologics are medicines derived from living organisms like human beings, animals, or other microorganisms using biotechnology and are composed of proteins, sugar, nucleic acids, or a combination of each of these substances. Due to their ability to target inaccessible parts using small-molecule therapies, biologics are being preferred over traditional chemical drugs. This shift is restricting the antidiarrheal drugs market hampering its growth of the market. For example, to treat Crohn’s Disease, antidiarrheal medications were being used previously, but with the advent of biologics, demand for antidiarrheal diseases has subsided.
Major companies in the antidiarrheal drug market are merging with other companies in the market to increase their reach and market share. Companies merge with or acquire other companies to expand their market share, diversify their product portfolio, or acquire new technologies. For instance, GlaxoSmithKline agreed to acquire Novartis AG's 36.5% stake in the consumer healthcare business for $ 13 billion to expand the market.
The antidiarrheal drug industry is governed by regulatory frameworks by agencies such as US Food and Drug Administration Agency (FDA). FDA's guidelines for antidiarrheal drugs are mentioned within the CFR's (Code for Federal Regulations) title number 21 under part 335 which gives guidelines for the over-the-counter (OTC) human use of the antidiarrheal drugs. Subpart C of the regulation focuses on the labeling aspect of such drugs and mandates a statement of identity, which identifies the product is to be used for diarrhea to avoid any improper use of the drug. The FDA also regulates the warnings and directions of use of the drugs which are to be printed on the cover of these drugs.
In March 2020, Arcadia Consumer Healthcare, Inc., a USA-based pharmaceutical company acquired the Kaopectate brand from Sanofi for an undisclosed amount. This acquisition enhanced Sanofi’s product portfolio by providing consumers with simple, efficacious, and high-quality solutions. Sanofi, is a France-based biopharmaceutical company focused on human health.
The regions covered in the antidiarrhoeals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antidiarrhoeals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The antidiarrheal drugs market research report is one of a series of new reports that provides antidiarrheal drugs market statistics, including antidiarrheal drugs industry global market size, regional shares, competitors with antidiarrheal drugs market share, detailed antidiarrheal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the antidiarrheal drugs industry. This antidiarrheal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the antidiarrhoeals market are GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals, Merck & Co., Pfizer, Proctor & Gamble, Sanofi Aventis and Bayer.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Anti-diarrheal Drugs Market Characteristics
3. Anti-diarrheal Drugs Market Trends And Strategies
4. Anti-diarrheal Drugs Market - Macro Economic Scenario
4.1 COVID-19 Impact On Anti-diarrheal Drugs Market
4.2 Ukraine-Russia War Impact On Anti-diarrheal Drugs Market
4.3 Impact Of High Inflation On Anti-diarrheal Drugs Market
5. Anti-diarrheal Drugs Market Size And Growth
5.1. Global Anti-diarrheal Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Anti-diarrheal Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Anti-diarrheal Drugs Market Segmentation
6.1. Global Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Mucosal Protectants
- Motility Modifying Drugs
- Adults
- Childrens
- OTC drugs
- Prescription Drugs
7.1. Global Anti-diarrheal Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Anti-diarrheal Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Anti-diarrheal Drugs Market
8.1. Asia-Pacific Anti-diarrheal Drugs Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.3. Asia-Pacific Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Anti-diarrheal Drugs Market
9.1. China Anti-diarrheal Drugs Market Overview
9.2. China Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Anti-diarrheal Drugs Market
10.1. India Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Anti-diarrheal Drugs Market
11.1. Japan Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Anti-diarrheal Drugs Market
12.1. Australia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Anti-diarrheal Drugs Market
13.1. Indonesia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Anti-diarrheal Drugs Market
14.1. South Korea Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Anti-diarrheal Drugs Market
15.1. Western Europe Anti-diarrheal Drugs Market Overview
15.2. Western Europe Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Anti-diarrheal Drugs Market
16.1. UK Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Anti-diarrheal Drugs Market
17.1. Germany Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Anti-diarrheal Drugs Market
18.1. France Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Anti-diarrheal Drugs Market
19.1. Eastern Europe Anti-diarrheal Drugs Market Overview
19.2. Eastern Europe Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Anti-diarrheal Drugs Market
20.1. Russia Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Anti-diarrheal Drugs Market
21.1. North America Anti-diarrheal Drugs Market Overview
21.2. North America Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Anti-diarrheal Drugs Market
22.1. USA Anti-diarrheal Drugs Market Overview
22.2. USA Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Anti-diarrheal Drugs Market
23.1. South America Anti-diarrheal Drugs Market Overview
23.2. South America Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Anti-diarrheal Drugs Market
24.1. Brazil Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Anti-diarrheal Drugs Market
25.1. Middle East Anti-diarrheal Drugs Market Overview
25.2. Middle East Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Anti-diarrheal Drugs Market
26.1. Africa Anti-diarrheal Drugs Market Overview
26.2. Africa Anti-diarrheal Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Anti-diarrheal Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Anti-diarrheal Drugs Market Competitive Landscape And Company Profiles
27.1. Anti-diarrheal Drugs Market Competitive Landscape
27.2. Anti-diarrheal Drugs Market Company Profiles
27.2.1. GlaxoSmithKline
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Actelion
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Perrigo
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Lupin
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Glenmark Pharmaceuticals
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Anti-diarrheal Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Anti-diarrheal Drugs Market
30. Anti-diarrheal Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. About the Publisher
31.6. Copyright And Disclaimer
Executive Summary
Antidiarrhoeals Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on antidiarrhoeals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered
1) By Drug Class: Mucosal Protectants; Motility Modifying Drugs2) By Application: Adults; Childrens
3) By Type: OTC drugs; Prescription Drugs
Companies Mentioned: GlaxoSmithKline; Actelion; Perrigo; Lupin; Glenmark Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- GlaxoSmithKline
- Actelion
- Perrigo
- Lupin
- Glenmark Pharmaceuticals
- Merck & Co.
- Pfizer
- Proctor & Gamble
- Sanofi Aventis
- Bayer
- Jhonson and Jhonson
- Novartis
- Kroger Company
- Harmon Store Inc.
- Great Lakes Wholesale Marketing and Sales
- Geri Care Pharmaceutical Corp
- Freds Inc.
- DOLGEN Corporation
- CVS Pharmacy
- American Sales Company
- Cardinal Health
- Bedrock LLC
- Greenbrier International
- Good Neighbour Pharmacy
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 3.94 billion |
| Forecasted Market Value ( USD | $ 4.31 billion |
| Compound Annual Growth Rate | 2.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
